| http://www.w3.org/ns/prov#value | - Such diseases and conditions treated by muscarinic receptor modulators include Alzheimer's disease, glaucoma, mania, bipolar disorder, depression, sleeping disorders, epilepsy, gastrointestinal motility disorders, urinary incontinence, pain, psychosis, particularly schizophrenia or schizophreniform conditions, and cognition enhancement, such as enhancement of learning, association, consolidation,
|
